カルナバイオサイエンス
売上高
損益
EPS
利益率
コスト

損益計算書

2015-12千円
2016-12千円
2017-12千円
2018-12千円
2019-12千円
2020-12千円
2021-12千円
2022-12千円
2023-12千円
2024-12千円
売上高1,569,205811,598657,516754,6913,207,4231,133,3462,017,5291,386,7481,625,889636,235
売上原価269,594254,425222,502250,699207,590192,149135,387171,550175,293170,542
売上総利益1,299,611557,172435,013503,9922,999,833941,1961,882,1411,215,1971,450,595465,692
販売費及び一般管理費826,829981,1491,134,0741,648,5112,022,0551,998,2642,413,2772,485,0862,567,5742,541,797
営業損失(△)472,781-423,977-699,060-1,144,519977,778-1,057,067-531,135-1,269,888-1,116,978-2,076,104
営業外収益
受取利息188115401635112410714717014,504
受取配当金---367379389399411426442
為替差益----2,362-14,425830-26,446
その他1,7601,5771,1652851892378371,2431592,703
受取保険金-------1,957--
助成金収入---446-1,9991,3461,000--
補助金収入29,2408,6925,381---7,200---
営業外収益合計31,19010,3856,5871,1153,2822,74924,3155,59075644,097
営業外費用
支払利息2,2875,6606,90110,6288,1647,3733,9255,3103,4512,958
支払保証料---1,8431,7361,4761,336977676396
株式交付費2,4521,4671,8582,8878,0084,3733,7662,6825,21945,377
為替差損4,57615,9672,133387-9,540--714-
その他7471,3531,95073525141,190490-
新株予約権発行費------5,9525,501--
新株予約権発行費----5,465-----
新株予約権発行費1,674-6,178-------
社債発行費-2,617--------
営業外費用合計11,73927,06619,02315,82023,90022,77816,17214,52210,06148,732
経常損失(△)492,233-440,657-711,496-1,159,223957,161-1,077,096-522,992-1,278,820-1,126,283-2,080,739
特別損失
減損損失8,42525,81121,88447,57544,10126,3909,50744,5784,56293,237
特別損失合計8,42525,81121,88447,57544,10126,3909,50744,5784,56293,237
税金等調整前当期純損失(△)486,090-288,926-733,380-1,206,799913,059-1,102,487-532,499-1,323,399-1,130,846-2,173,976
法人税、住民税及び事業税30,2351,3494,0653,94184,9253,0157,78026,26222,1614,704
法人税等調整額-533-335-181-167-1555,529-5,805-122-113-104
法人税等合計29,7011,0143,8833,77384,7708,5451,97526,14022,0484,599
当期純損失(△)--289,940-737,264-1,210,573828,289-1,111,032-534,474-1,349,539-1,152,895-2,178,576
親会社株主に帰属する当期純損失(△)--289,940-737,264-1,210,573828,289-1,111,032-534,474-1,349,539-1,152,895-2,178,576
特別利益
新株予約権戻入益2,282----1,000----
投資有価証券売却益-177,543--------
特別利益合計2,282177,543---1,000----
少数株主損益調整前当期純利益又は少数株主損益調整前当期純損失(△)456,388---------
当期純利益又は当期純損失(△)456,388---------